Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
    • nicolauz@feddit.orgEnglish
      1·
      8 minutes ago

      I don’t understand why you used “but”, where it should clearly be “as well as”…